1. Home
  2. Browse
  3. HRA005236
HRA005236
   HRA005236.xlsx
Title:
Molecular characterization of long-term glioblastoma survivors
Release date:
2023-09-01
Description:
Only fewer than 5% GBM patients survive over 5 years and referred as long-term survivors (LTS), yet the underlying molecular background of these LTS are insufficiently understood. Herein, we employed comprehensive whole exome sequencing (WES), RNA-seq and methylation array to delineate molecular landscape of the largest LTS cohort to date. Our cohort consisted of 78 primary GBM patients and were divided into LTS (n = 37) and short-term survivors (STS, OS <= 24 months, n = 41), all confirmed being isocitrate dehydrogenase (IDH)-wildtype. These is the raw data of WES, RNAseq, and Bisulfite sequencing of the project.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA018782
Study type:
Cohort Study
Disease name:
glioblastoma multiforme
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC002922
DAC name:
hao Xu, Zhiyong Qin Group
Contact person:
Qin Zhiyong
Email:
qinzhiyong@fudan.edu.cn
Description:
The Committee controls the data usage and approvals on requests of the data uploaded by the members in Zhiyong Qin research Group, Neurosurgical Oncology, HuaShan Hospital, China.
Individuals & samples
Files
Request Data
Submitter:   Qin Zhiyong / qinzhiyong@fudan.edu.cn
Organization:   Huashan Hospital Fudan University
Submission date:   2023-08-02
Requests:   -